Evonik has closed the $640 million acquisition of PeroxyChem from One Equity Partners, after a lawsuit to block it filed by the Federal Trade Commission in August 2019 was rejected.
WeylChem has announced that it is investing a sum “in the range of high single-digit millions euros” to upgrade a multi-purpose plant at the site of its Allessa custom and toll manufacturing subsidiary.
Carolyn Buller of Squire Patton Boggs offers her perspective on the state of the industry at the turn of the decade.
Lonza has announced results for 2019, in which its growth was entirely driven by the Pharma Biotech & Nutrition division on which it will base its future.
The Chemical Business Association, which represents chemical distributors in the UK, has joined other associations in responding critically to Chancellor Sajid Javid’s recent statement that there would be no regulatory alignment with the EU following Brexit.
CDMO Piramal Pharma Solutions business is to expand its Aurora facility in Aurora, Toronto, by investing C$25 million in a new API wing.
Lanxess has implemented Software AG’s TrendMiner self-service analytics system for time-series data in about two thirds of its 120 plants, including all of its major production sites in Germany, Belgium, the US and India.
Clariant Refinery Services officially opened a new crude and fuel oil laboratory at Bradford, UK, on 23 January.
Mike Beason, EMEA distribution, director of automated data analytics supplier Anvizent, explores a series of factors to consider in order to make an informed decision when selecting an analytics system.
Current Issue
Evonik has closed the $640 million acquisition of PeroxyChem from One Equity Partners, after a lawsuit to block it filed by the Federal Trade Commission in August 2019 was rejected.
WeylChem has announced that it is investing a sum “in the range of high single-digit millions euros” to upgrade a multi-purpose plant at the site of its Allessa custom and toll manufacturing subsidiary.
Carolyn Buller of Squire Patton Boggs offers her perspective on the state of the industry at the turn of the decade.
Lonza has announced results for 2019, in which its growth was entirely driven by the Pharma Biotech & Nutrition division on which it will base its future.
Most Popular
BASF and private equity firm Lone Star are in exclusive negotiations for the sale of BASF’s construction chemicals business, according to news agency Bloomberg.
According to a story given by company insiders to the news agency Bloomberg, Merck KGaA is considering the sale of its Effect Pigments business.
ChemChina and Sinochem have announced that they are consolidating their agricultural assets into a new holding company that will be called Syngenta Group.
